Ripasudil hydrochloride dihydrate

Ripasudil hydrochloride dihydrate is an inhibitor of ROCK1 and ROCK2 used in studies of kinase signaling. It is especially relevant when investigators need a named chemical input and interpretable readouts connected to phosphorylation signaling, target engagement, and selectivity relationships in cancer, cardiovascular, and cell cycle models.

By inhibiting ROCK1 and ROCK2, Ripasudil hydrochloride dihydrate can be used to examine phosphorylation signaling, target engagement, and selectivity relationships. This target class is commonly examined through biochemical kinase assays, phospho-signaling studies, and selectivity profiling, together with downstream-response mapping. In cancer, cardiovascular, and cell cycle models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving ROCK1 and ROCK2
• Concentration-response inhibition and target-dependence studies
• Biochemical kinase assays, phospho-signaling studies, and selectivity profiling
• Phenotypic profiling in cancer, cardiovascular, and cell cycle models

Overall, Ripasudil hydrochloride dihydrate is appropriate when a defined chemical perturbant is needed to connect ROCK1 and ROCK2 with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in cancer, cardiovascular, and cell cycle models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.